As compared with the levels detected in healthy control PBMCs, C/EBPβ, NTT, and PBOV1 expressions were significantly elevated in freshly diagnosed RA patients (median folds for C/EBPβ = 10.13, NTT = 369.76, PBOV1 = 7455.33), and the levels markedly decreased after 2-year treatment (Figure 3A–C). The gene discussed is CEBPB; the disease is rheumatoid arthritis.